REQUEST INFO

TDF Drug and Truvada Lawsuit


We are filing lawsuits on behalf of people with HIV who took one or more of Gileadโ€™s Tenofovir Disoproxil Fumarate (TDF) drugsโ€”Truvada, Viread, Atripla, Complera, and Stribildโ€”and then allegedly suffered kidney disease and/or bone density loss.
Have you been impacted? Use the contact form, or call us at 1-800-567-4878, to see how Diamond & Diamond Lawyers can help.

About the Class Action / Mass Tort

The risks associated with Tenofovir were well-understood by the Defendants at the time they began developing and testing TDF-based drugs. 

As a result of taking the TDF-based drugs, individuals suffered harm and injuries including, but not limited to, decreased kidney function, renal failure, end-stage renal disease, renal impairment, chronic kidney disease, tubular dysfunction, chronic liver disease, Fanconi syndrome, reduced bone density, bone breaks/fractures, bone malformation, and tooth loss. 

This claim is being brought on behalf of all individuals who, during the period 2004 to the present were prescribed and ingested TDF-based drugs in Canada and experienced any of the harm and injuries described above.



Updates (Related to the Class Action / Mass Tort)

June 2024:

We write to provide you with a further update beyond the update provided in December 2023. We are currently in the process of moving our clients over to a mass tort by way of individual actions. Please let us know if you have not been contacted yet to confirm whether you will be proceeding individually. We are currently working on drafting statement of claims and will be in touch with you as more information is required for your individual files.

December 2023:

We write to provide you with a further update beyond the update provided in July. We are currently in the process of moving our clients over to a mass tort by way of individual actions. Please let us know if you have not been contacted yet. We are currently working on drafting a statement of claims and will be in touch with you as more information is required for your individual files.

July 2023:

We write to provide you with a further update beyond the update provided in March. We are currently in the process of moving our clients over to a mass tort by way of individual actions. Please let us know if you have not been contacted yet. By way of background, a mass tort does not have one representative plaintiff, but rather multiple lawsuits that are settled on an individual basis. A mass tort allows the individual to have complete control over their own case and can decide their own settlement. We are currently working on drafting statement of claims and will be in touch with you as more information is required for your individual files.

March 2023:

We write to provide you with a further update beyond the update provided in December.  We are currently in the process of moving our clients over to a mass tort by way of individual actions. Please let us know if you have not been contacted yet. By way of background, a mass tort does not have one representative plaintiff, rather multiple lawsuits that are settled on an individual basis. A mass tort allows the individual to have complete control over their own case and can decide their own settlement. We are currently working on drafting statement of claims and will be in touch with you as more information is required for your individual files.

December 2022:

We write to provide you with a further update beyond the update provided in August. We are currently in the process of conducting internal meetings to discuss next steps to progress this matter in a favourable jurisdiction and manner. Once these talks have been completed and a decision is made, we will provide a further update.

August 2022:

Further to our April update, we write to provide you with a further update. We are currently in the process of conducting internal meetings to discuss next steps to progress this matter in a favourable jurisdiction. Once these talks have been completed and a decision is made, we will provide a further update.

April 2022:

We write to provide you with a further update to our December update. As mentioned in our last update, we have issued our Statement of Claim. We are currently in the process of conducting internal meetings to discuss next steps. Once these talks have been completed, we will provide a further update.

December 2021:

We write to provide you with a further update to our August update. As mentioned in our last update, we have issued our Statement of Claim. We are awaiting a response from defence counsel and will be moving towards booking our first court appearance.

August 2021:

We write to provide you with a further update to our June 9th update. As mentioned in our last update, we are currently drafting a Statement of Claim and anticipate that claim will be issued in the near future. Once the claim is issued we will be proceeding with the next steps, which include booking a first court appearance.


Get in Touch With Us Today

Details about the Class Action / Mass Tort

The proposed lawsuit alleges that the maker of these drugs knew that there was a safer alternative to TDF and knowingly delayed and withheld the development, marketing and sale of the alternative, to maximize their profit from sales of Viread, Truvada, Atripla, Complera and Stribild. 

Due to the Defendantsโ€™ actions, Canadians were exposed to the more toxic and dangerous medication for over a decade and suffered permanent, debilitating, and sometimes fatal, injuries and harm relating to kidney and bone damage.

Have you or your family member been impacted? Use the contact form, or call us at 1-800-567-4878, to see how Diamond & Diamond Lawyers can help.

Diamond and Diamond Files Class Action Suit against York University and York Federation of Students

  $15 Million Lawsuit Alleges Recurring Anti-Semitic Incidents and Seeks Meaningful Reform Toronto, ON โ€“ Diamond and Diamond Lawyers have initiated a class action lawsuit…

Read More >>

Get the help you deserve

1-800-567-HURT

Call NOW for a free consultation

 

Diamond & Diamond Ontario Head Office

255 Consumers Road, 5th Floor, Toronto, Ontario

>> Learn More

Diamond & Diamond Alberta Head Office

4246 97 Street NW, Unit 103, Edmonton, Alberta

>> Learn More

Diamond & Diamond British Columbia Head Office

1727 West Broadway, Suite 400, Vancouver, British Columbia

>> Learn More

Barrie

168 Bayfield Street

Calgary

1331 Macleod Trail SE, Suite 645

Edmonton

4246 97 Street NW, Unit 103

Halifax

1701 Hollis St

London

256 Pall Mall St, Suite 102

Oshawa

50 Richmond Street E, Unit # 108 B

Ottawa

955 Green Valley Crescent, Unit 315

Sudbury

31 Larch Street, Unit 300

Toronto

255 Consumers Road, 5th Floor

Vancouver

1727 West Broadway, Suite 400

Windsor

13158 Tecumseh Rd. E. Unit 3B

Maritimes